Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

FDA Finalizes Guidance on MFS as End Point for Prostate Cancer Clinical Trials,

The FDA has finalized guidance on the use of metastasis-free survival (MFS) as an end point in clinical trials for nonmetastatic castration-resistant …, The FDA has finalized guidance on the use of metastasis-free survival (MFS) as an end point in clinical trials for nonmetastatic castration-resistant …, Read More

Scroll to Top